These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8779)

  • 1. Binding of [3H]dihydroazapetine to alpha-adrenoreceptor-related proteins from rat vas deferens.
    Ruffolo RR; Fowble JW; Miller DD; Patil PN
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2730-4. PubMed ID: 8779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further biochemical characterization of [3H]dihydroazapetine binding to alpha-adrenoceptorrelated proteins from the rat vas deferens.
    Ruffolo RR; Turowski BS; Patil PN
    J Pharm Pharmacol; 1978 Aug; 30(8):498-502. PubMed ID: 28398
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of accumulation, efflux and the pharmacological effects of tritiated dihydroazapetine on the rabbit aorta.
    Ruffolo RR; Fowble JW; Miller DD; Patil PN
    J Pharmacol Exp Ther; 1977 Aug; 202(2):278-86. PubMed ID: 18596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA; Marks BH
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.
    Alberts P
    Acta Physiol Scand Suppl; 1982; 506():1-39. PubMed ID: 6293252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.
    Zatz M; Kebabian JW; Romero JA; Lefkowitz RJ; Axelrod J
    J Pharmacol Exp Ther; 1976 Mar; 196(3):714-22. PubMed ID: 4608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA.
    Sharpe IA; Thomas L; Loughnan M; Motin L; Palant E; Croker DE; Alewood D; Chen S; Graham RM; Alewood PF; Adams DJ; Lewis RJ
    J Biol Chem; 2003 Sep; 278(36):34451-7. PubMed ID: 12824165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postganglionic denervation and pretreatment with reserpine on alpha-adrenoceptors of the guinea-pig vas deferens.
    Cowan FF; Wong SK; Westfall DP; Fleming WW
    Pharmacology; 1985; 30(5):289-95. PubMed ID: 2860677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine.
    Han C; Abel PW; Minneman KP
    Mol Pharmacol; 1987 Oct; 32(4):505-10. PubMed ID: 2890094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and alpha-adrenoreceptor blocking properties of phenoxybenzamine-related (2-chloroethyl)-(2,3-dihydrobenzo[1,4]dioxin- 2-ylmethyl)-(2-phenoxyethyl) amines.
    Giardinà D; Crucianelli M; Marucci G; Paparelli F; Melchiorre C
    Bioorg Med Chem; 1995 Jan; 3(1):85-94. PubMed ID: 8612050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective stimulation of PGE1-synthesis by soterenol in the isolated rat vas deferens is mediated by alpha adrenoreceptors.
    Borda E; del C Agostini M; Gimeno MF; Gimeno AL
    Prostaglandins Leukot Med; 1982 May; 8(5):531-6. PubMed ID: 6285389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic implications of alpha-adrenoreceptor interactive parameters for epinephrine enantiomers in the rat vas deferens.
    Rice PJ; Miller DD; Sokoloski TD; Patil PN
    Chirality; 1989; 1(1):14-9. PubMed ID: 2561990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in 1,4-benzodioxan-related compounds. 5. Effects of modification of the side chain on alpha-adrenoreceptor blocking activity.
    Quaglia W; Giannella M; Marucci G; Piergentili A; Pigini M; Tayebati SK; Melchiorre C
    Farmaco; 1996 Jan; 51(1):27-32. PubMed ID: 8721758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
    Alexander RW; Williams LT; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1564-8. PubMed ID: 1055427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of G-protein βγ subunits on the influence of inhibitory α2-autoreceptors on the angiotensin AT1-receptor modulation of noradrenaline release in the rat vas deferens.
    Talaia C; Queiroz G; Pinheiro H; Moura D; Gonçalves J
    Neurochem Int; 2006 Dec; 49(7):698-707. PubMed ID: 16962210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline desensitization of epinephrine responses in rat vas deferens.
    Rice PJ; Hardin JC; Hamdi A; Abraham ST
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1182-7. PubMed ID: 1684817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.